Evaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney disease

Levente Babos1, Zoltán Járai, János Nemcsik

  • 1Levente Babos, János Nemcsik, Department of Family Medicine, Semmelweis University, 1125 Budapest, Hungary.

World Journal of Nephrology
|November 21, 2013
PubMed

Insights

Early diagnosis of endothelial dysfunction (ED) in chronic kidney disease (CKD) is crucial for managing cardiovascular disease mortality. Laser Doppler flowmetry (LDF) offers a non-invasive method to assess microcirculation and ED in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular diseases are a leading cause of mortality in chronic kidney disease (CKD) patients.
  • Accelerated atherosclerosis and endothelial dysfunction (ED) are key contributors to this mortality.
  • Early detection of ED is vital for timely interventions and improved patient outcomes.

Purpose of the Study:

  • To review diagnostic methodologies for endothelial dysfunction (ED) in chronic kidney disease (CKD).
  • To focus on Laser Doppler flowmetry (LDF) based tests for ED assessment.
  • To summarize current data on LDF applications in CKD patients for clinical utility.

Main Methods:

  • Review of various Laser Doppler flowmetry (LDF) tests for endothelial dysfunction (ED) diagnosis.
  • Specific LDF methods discussed include postocclusive reactive hyperemia, local heating, iontophoresis, microdialysis, and flowmotion analysis.
  • Synthesis of existing research data on LDF in chronic kidney disease (CKD) populations.

Main Results:

  • Laser Doppler flowmetry (LDF) provides continuous, non-invasive microcirculation monitoring.
  • Various LDF-based tests have been developed for assessing endothelial dysfunction (ED).
  • Data on LDF application in chronic kidney disease (CKD) patients requires further summarization for clinical relevance.

Conclusions:

  • Endothelial dysfunction (ED) is an early event in the accelerated atherosclerosis of chronic kidney disease (CKD).
  • Laser Doppler flowmetry (LDF) offers promising non-invasive techniques for ED diagnosis in CKD.
  • Further research and data synthesis are needed to establish LDF's clinical role in managing CKD patients.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
49
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
146
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
702